255 related articles for article (PubMed ID: 36899894)
1. Age-Dependent Dysregulation of APP in Neuronal and Skin Cells from Fragile X Individuals.
Cencelli G; Pacini L; De Luca A; Messia I; Gentile A; Kang Y; Nobile V; Tabolacci E; Jin P; Farace MG; Bagni C
Cells; 2023 Feb; 12(5):. PubMed ID: 36899894
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome.
Pasciuto E; Ahmed T; Wahle T; Gardoni F; D'Andrea L; Pacini L; Jacquemont S; Tassone F; Balschun D; Dotti CG; Callaerts-Vegh Z; D'Hooge R; Müller UC; Di Luca M; De Strooper B; Bagni C
Neuron; 2015 Jul; 87(2):382-98. PubMed ID: 26182420
[TBL] [Abstract][Full Text] [Related]
3. Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism.
Westmark CJ; Sokol DK; Maloney B; Lahiri DK
Mol Psychiatry; 2016 Oct; 21(10):1333-41. PubMed ID: 27573877
[TBL] [Abstract][Full Text] [Related]
4. Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue.
Ray B; Sokol DK; Maloney B; Lahiri DK
Sci Rep; 2016 May; 6():26052. PubMed ID: 27212113
[TBL] [Abstract][Full Text] [Related]
5. Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links.
Sokol DK; Maloney B; Long JM; Ray B; Lahiri DK
Neurology; 2011 Apr; 76(15):1344-52. PubMed ID: 21482951
[TBL] [Abstract][Full Text] [Related]
6. Serum matrix metalloproteinase-9 (MMP9) and amyloid-beta protein precursor (APP) as potential biomarkers in children with Fragile-X syndrome: A cross sectional study.
Bekheet MHY; Mansour LA; Elkaffas RH; Kamel MA; Elmonem MA
Clin Biochem; 2023 Nov; 121-122():110659. PubMed ID: 37797798
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
[TBL] [Abstract][Full Text] [Related]
8. Fragile X Syndrome Patient-Derived Neurons Developing in the Mouse Brain Show FMR1-Dependent Phenotypes.
Krzisch MA; Wu H; Yuan B; Whitfield TW; Liu XS; Fu D; Garrett-Engele CM; Khalil AS; Lungjangwa T; Shih J; Chang AN; Warren S; Cacace A; Andrykovich KR; Rietjens RGJ; Wallace O; Sur M; Jain B; Jaenisch R
Biol Psychiatry; 2023 Jan; 93(1):71-81. PubMed ID: 36372569
[TBL] [Abstract][Full Text] [Related]
9. Cell-type-specific profiling of human cellular models of fragile X syndrome reveal PI3K-dependent defects in translation and neurogenesis.
Raj N; McEachin ZT; Harousseau W; Zhou Y; Zhang F; Merritt-Garza ME; Taliaferro JM; Kalinowska M; Marro SG; Hales CM; Berry-Kravis E; Wolf-Ochoa MW; Martinez-Cerdeño V; Wernig M; Chen L; Klann E; Warren ST; Jin P; Wen Z; Bassell GJ
Cell Rep; 2021 Apr; 35(2):108991. PubMed ID: 33852833
[TBL] [Abstract][Full Text] [Related]
10. Peripheral Amyloid Precursor Protein Derivative Expression in Fragile X Syndrome.
McLane RD; Schmitt LM; Pedapati EV; Shaffer RC; Dominick KC; Horn PS; Gross C; Erickson CA
Front Integr Neurosci; 2019; 13():49. PubMed ID: 31551722
[TBL] [Abstract][Full Text] [Related]
11. Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons.
Graef JD; Wu H; Ng C; Sun C; Villegas V; Qadir D; Jesseman K; Warren ST; Jaenisch R; Cacace A; Wallace O
Eur J Neurosci; 2020 May; 51(10):2143-2157. PubMed ID: 31880363
[TBL] [Abstract][Full Text] [Related]
12. Impact of acamprosate on plasma amyloid-β precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker.
Erickson CA; Ray B; Maloney B; Wink LK; Bowers K; Schaefer TL; McDougle CJ; Sokol DK; Lahiri DK
J Psychiatr Res; 2014 Dec; 59():220-8. PubMed ID: 25300441
[TBL] [Abstract][Full Text] [Related]
13. Deletion of Fmr1 in parvalbumin-expressing neurons results in dysregulated translation and selective behavioral deficits associated with fragile X syndrome.
Kalinowska M; van der Lei MB; Kitiashvili M; Mamcarz M; Oliveira MM; Longo F; Klann E
Mol Autism; 2022 Jun; 13(1):29. PubMed ID: 35768828
[TBL] [Abstract][Full Text] [Related]
14. Protein synthesis levels are increased in a subset of individuals with fragile X syndrome.
Jacquemont S; Pacini L; Jønch AE; Cencelli G; Rozenberg I; He Y; D'Andrea L; Pedini G; Eldeeb M; Willemsen R; Gasparini F; Tassone F; Hagerman R; Gomez-Mancilla B; Bagni C
Hum Mol Genet; 2018 Jun; 27(12):2039-2051. PubMed ID: 29590342
[TBL] [Abstract][Full Text] [Related]
15. Integrated transcriptome analysis of human iPS cells derived from a fragile X syndrome patient during neuronal differentiation.
Lu P; Chen X; Feng Y; Zeng Q; Jiang C; Zhu X; Fan G; Xue Z
Sci China Life Sci; 2016 Nov; 59(11):1093-1105. PubMed ID: 27730449
[TBL] [Abstract][Full Text] [Related]
16. Maturation Delay of Human GABAergic Neurogenesis in Fragile X Syndrome Pluripotent Stem Cells.
Zhang A; Sokolova I; Domissy A; Davis J; Rao L; Hana Utami K; Wang Y; Hagerman RJ; Pouladi MA; Sanna P; Boland MJ; Loring JF
Stem Cells Transl Med; 2022 Jun; 11(6):613-629. PubMed ID: 35556144
[TBL] [Abstract][Full Text] [Related]
17. Human pluripotent stem cell models of Fragile X syndrome.
Bhattacharyya A; Zhao X
Mol Cell Neurosci; 2016 Jun; 73():43-51. PubMed ID: 26640241
[TBL] [Abstract][Full Text] [Related]
18. Melatonin as a Novel Interventional Candidate for Fragile X Syndrome with Autism Spectrum Disorder in Humans.
Won J; Jin Y; Choi J; Park S; Lee TH; Lee SR; Chang KT; Hong Y
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632163
[TBL] [Abstract][Full Text] [Related]
19. Loss of the fragile X mental retardation protein causes aberrant differentiation in human neural progenitor cells.
Sunamura N; Iwashita S; Enomoto K; Kadoshima T; Isono F
Sci Rep; 2018 Aug; 8(1):11585. PubMed ID: 30072797
[TBL] [Abstract][Full Text] [Related]
20. Fragile X and APP: a Decade in Review, a Vision for the Future.
Westmark CJ
Mol Neurobiol; 2019 Jun; 56(6):3904-3921. PubMed ID: 30225775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
